Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Spigel DR, Edelman MJ, O'Byrne K, Paz-Ares L, et al. Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung. J Clin Oncol 2017;35:412-420.
PMID: 27937096


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016